摘要
肺囊性纤维化肺部疾病的特点是慢性、非解决先天免疫系统的激活和过度释放细胞因子及趋化因子如IL-8和免疫细胞,主要是中性粒细胞持续浸润,进入呼吸道。慢性感染和受损的免疫反应,最终导致肺损伤的特点是支气管扩张、肺气肿、肺纤维化。作为一个完整解释在肺纤维化疾病的夸张的炎症反应的知识的途径是缺乏的,了解这些途径可以揭示新的治疗目标,并引领新的治疗。因此,此处有一个强有力的理由鉴定在肺疾病的机制和途径下夸张的炎症反应。本文综述了炎症的肺囊性纤维化肺部疾病的发病机制中的作用,对异常信号参与趋化因子IL-8和肺囊性纤维化航空公司招募中性粒细胞过度表达的重点。研究结果表明,针对在免疫细胞信号传导通路(尤其是中性粒细胞)夸张的IL-8/IL-8受体(主要是CXCR2)可能代表了肺囊性纤维化肺部疾病的一种潜在的治疗策略。
关键词: 囊性纤维化,肺部炎症、CFTR,趋化因子信号,IL-8,CXCR2,NF-κB。
图形摘要
Current Drug Targets
Title:Dysregulated Chemokine Signaling in Cystic Fibrosis Lung Disease: A Potential Therapeutic Target
Volume: 17 Issue: 13
Author(s): Xiaoqing Guan, Yuning Hou, Fei Sun, Zhe Yang, Chunying Li
Affiliation:
关键词: 囊性纤维化,肺部炎症、CFTR,趋化因子信号,IL-8,CXCR2,NF-κB。
摘要: CF lung disease is characterized by a chronic and non-resolving activation of the innate immune system with excessive release of chemokines/cytokines including IL-8 and persistent infiltration of immune cells, mainly neutrophils, into the airways. Chronic infection and impaired immune response eventually lead to pulmonary damage characterized by bronchiectasis, emphysema, and lung fibrosis. As a complete knowledge of the pathways responsible for the exaggerated inflammatory response in CF lung disease is lacking, understanding these pathways could reveal new therapeutic targets, and lead to novel treatments. Therefore, there is a strong rationale for the identification of mechanisms and pathways underlying the exaggerated inflammatory response in CF lung disease. This article reviews the role of inflammation in the pathogenesis of CF lung disease, with a focus on the dysregulated signaling involved in the overexpression of chemokine IL-8 and excessive recruitment of neutrophils in CF airways. The findings suggest that targeting the exaggerated IL-8/IL-8 receptor (mainly CXCR2) signaling pathway in immune cells (especially neutrophils) may represent a potential therapeutic strategy for CF lung disease.
Export Options
About this article
Cite this article as:
Xiaoqing Guan, Yuning Hou, Fei Sun, Zhe Yang, Chunying Li , Dysregulated Chemokine Signaling in Cystic Fibrosis Lung Disease: A Potential Therapeutic Target, Current Drug Targets 2016; 17 (13) . https://dx.doi.org/10.2174/1389450117666151209120516
DOI https://dx.doi.org/10.2174/1389450117666151209120516 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Anti-Cancer Effects of Citalopram on Hepatocellular Carcinoma Cells Occur via Cytochrome C Release and the Activation of NF-kB
Anti-Cancer Agents in Medicinal Chemistry Editorial [Hot Topic:Non-Receptor Tyrosine Kinases as Molecular Targets for Patient Tailored Cancer Therapy (Guest Editors: F.M. Uckun, A. Vassilev and H. Tibbles)]
Anti-Cancer Agents in Medicinal Chemistry Editorial: Looking Forward to Another Successful Year
Current Cancer Drug Targets Nanoemulsions for Improved Efficacy of Phytotherapeutics- A Patent Perspective
Recent Patents on Nanotechnology Anticarcinogenic Effects of Capsaicin-Loaded Nanoparticles on In vitro Hepatocellular Carcinoma
Current Chemical Biology Bypass Mechanisms of Resistance to Tyrosine Kinase Inhibition in Chronic Myelogenous Leukaemia
Current Drug Discovery Technologies Identification of Marker Genes for Cancer Based on Microarrays Using a Computational Biology Approach
Current Bioinformatics Segmentation and Classification of Lung Cancer: A Review
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Common and Uncommon Features of Rheumatoid Arthritis and Chronic Obstructive Pulmonary Disease: Clues to a Future Therapy
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Focal Adhesion Kinase as a Cancer Therapy Target
Anti-Cancer Agents in Medicinal Chemistry Alternative Polyadenylation and Its Impact on Cellular Processes
MicroRNA Tannic Acid Inhibits Proliferation, Migration, Invasion of Prostate Cancer and Modulates Drug Metabolizing and Antioxidant Enzymes
Anti-Cancer Agents in Medicinal Chemistry Anti-Cancer Natural Product Library from Traditional Chinese Medicine
Combinatorial Chemistry & High Throughput Screening Electrocatalytic Determination of 6-Mercaptopurine Using Multiwall Carbon Nanotubes Paste Electrode in the Presence of Methyldopa
Current Nanoscience Polypharmacology of Approved Anticancer Drugs
Current Drug Targets Shedding Light on Serum Vitamin D Concentrations and the Risk of Rarer Cancers
Anti-Cancer Agents in Medicinal Chemistry Dual Targeting of Glioma U251 Cells with Nanoparticles Prevents Tumor Angiogenesis and Inhibits Tumor Growth
Current Neurovascular Research Overview on Anticancer Drug Design and Development
Current Medicinal Chemistry Editorial [Hot Topic: Target Specificity of Effective Anticancer Therapeutics (Executive Editor: G. Capranico)]
Current Pharmaceutical Design Identification of Differentially Expressed Gene Using Robust Singular Value Decomposition
Current Bioinformatics